Ratings by H.C. Wainwright (Swayampakula Ramakanth)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/22/2023 | X4 Pharmaceuticals | XFOR | Maintain | Buy (N/A) |
|
Details | ||
| 3/10/2023 | electroCore Inc. | ECOR | Maintain | Buy (N/A) |
|
Details | ||
| 3/6/2023 | Asensus Surgical inc. | ASXC | Maintain | Buy (N/A) |
|
Details | ||
| 3/1/2023 | Ocugen, Inc. | OCGN | Maintain | Buy (N/A) |
|
Details | ||
| 2/27/2023 | Codexis, Inc. | CDXS | Maintain | Buy (N/A) |
|
Details | ||
| 2/24/2023 | Personalis | PSNL | Maintain | Buy (N/A) |
|
Details | ||
| 2/15/2023 | EDAP TMS S.A. | EDAP | Maintain | Buy (N/A) |
|
Details | ||
| 1/18/2023 | Leap Therapeutics | LPTX | Maintain | Buy (N/A) |
|
Details | ||
| 1/4/2023 | MediWound Ltd | MDWD | Maintain | Buy (N/A) |
|
Details | ||
| 1/4/2023 | Vericel Corporation | VCEL | Maintain | Buy (N/A) |
|
Details | ||
| 12/12/2022 | Affimed Therapeutics | AFMD | New Coverage | Buy (N/A) |
2.04 (0.66) |
-67.65% | Details | |
| 12/9/2022 | Corcept Therapeutics | CORT | Maintain | Buy (N/A) |
|
Details | ||
| 11/30/2022 | X4 Pharmaceuticals | XFOR | Maintain | Buy (N/A) |
|
Details | ||
| 11/18/2022 | EDAP TMS S.A. | EDAP | Maintain | Buy (N/A) |
|
Details | ||
| 11/16/2022 | MediWound Ltd | MDWD | Maintain | Buy (N/A) |
|
Details | ||
| 11/10/2022 | Vericel Corporation | VCEL | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2022 | ALX Oncology | ALXO | Maintain | Buy (N/A) |
|
Details | ||
| 11/7/2022 | Verastem | VSTM | Maintain | Buy (N/A) |
|
Details | ||
| 11/7/2022 | Codexis, Inc. | CDXS | Maintain | Buy (N/A) |
|
Details | ||
| 11/3/2022 | Surface Oncology | SURF | Maintain | Buy (N/A) |
|
Details | ||
| 11/3/2022 | Personalis | PSNL | Maintain | Buy (N/A) |
|
Details | ||
| 10/18/2022 | AVEO Pharmaceuticals | AVEO | Downgrade | Neutral (Buy) |
10.48 (15.00) |
43.13% | Details | |
| 8/30/2022 | IN8bio Inc. | INAB | New Coverage | Buy (N/A) |
1.98 (1.23) |
-37.88% | Details | |
| 8/29/2022 | Calithera Biosciences | CALA | Upgrade | Buy (Neutral) |
3.27 (0.37) |
-88.69% | Details | |
| 8/16/2022 | Diffusion Pharma | DFFN | Upgrade | Buy (Neutral) |
7.00 (5.62) |
-19.71% | Details | |
| 8/9/2022 | Precigen Inc. | PGEN | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2022 | Surface Oncology | SURF | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2022 | Codexis, Inc. | CDXS | Maintain | Buy (N/A) |
|
Details | ||
| 7/20/2022 | Vascular Biogenics Ltd | VBLT | Downgrade | Neutral (Buy) |
2.05 (0.16) |
-92.2% | Details | |
| 6/22/2022 | Celularity | CELU | New Coverage | Buy (N/A) |
3.78 (0.59) |
-84.39% | Details | |
| 5/13/2022 | X4 Pharmaceuticals | XFOR | Maintain | Buy (N/A) |
|
Details | ||
| 5/13/2022 | Pulse Biosciences | PLSE | Downgrade | Neutral (Buy) |
1.48 (2.82) |
90.54% | Details | |
| 3/1/2022 | ALX Oncology | ALXO | Maintain | Buy (N/A) |
|
Details | ||
| 2/25/2022 | Personalis | PSNL | Maintain | Buy (N/A) |
|
Details | ||
| 2/17/2022 | HOOKIPA Pharma Inc. | HOOK | Maintain | Buy (N/A) |
|
Details | ||
| 2/10/2022 | Pulse Biosciences | PLSE | Maintain | Buy (N/A) |
|
Details | ||
| 12/17/2021 | Vor Biopharma, Inc. | VOR | New Coverage | Buy (N/A) |
12.13 (5.88) |
-51.53% | Details | |
| 12/13/2021 | iTeos Therapeutics | ITOS | Maintain | Buy (N/A) |
|
Details | ||
| 12/10/2021 | Delcath Systems | DCTH | New Coverage | Buy (N/A) |
8.02 (4.84) |
-39.65% | Details | |
| 11/16/2021 | Pulse Biosciences | PLSE | Maintain | Buy (N/A) |
|
Details | ||
| 11/8/2021 | Calithera Biosciences | CALA | Downgrade | Neutral (Buy) |
0.86 (0.37) |
-56.98% | Details | |
| 10/18/2021 | Codexis, Inc. | CDXS | Maintain | Buy (N/A) |
|
Details | ||
| 8/23/2021 | Trillium Therapeutics | TRIL | Downgrade | Neutral (Buy) |
6.09 (18.44) |
202.79% | Details | |
| 8/16/2021 | Sesen Bio, Inc | SESN | Downgrade | Neutral (Buy) |
2.11 (0.63) |
-70.14% | Details | |
| 7/12/2021 | AVEO Pharmaceuticals | AVEO | Maintain | Buy (N/A) |
|
Details | ||
| 7/6/2021 | Janux Therapeutics | JANX | New Coverage | Buy (N/A) |
25.40 (11.50) |
-54.72% | Details | |
| 6/23/2021 | Corcept Therapeutics | CORT | Maintain | Buy (N/A) |
|
Details | ||
| 6/17/2021 | Kindred Biosciences | KIN | Downgrade | Neutral (Buy) |
9.23 (9.25) |
0.22% | Details | |
| 5/5/2021 | iTeos Therapeutics | ITOS | New Coverage | Buy (N/A) |
23.03 (13.63) |
-40.82% | Details | |
| 4/1/2021 | EDAP TMS S.A. | EDAP | Maintain | Buy (N/A) |
|
Details | ||
| 3/2/2021 | Ocugen, Inc. | OCGN | Maintain | Buy (N/A) |
|
Details | ||
| 3/1/2021 | ZIOPHARM Oncology | ZIOP | Downgrade | Neutral (Buy) |
5.33 (0.87) |
-83.68% | Details | |
| 2/17/2021 | Sesen Bio, Inc | SESN | Maintain | Buy (N/A) |
|
Details | ||
| 2/10/2021 | ALX Oncology | ALXO | New Coverage | Buy (N/A) |
82.18 (4.66) |
-94.33% | Details | |
| 2/4/2021 | Ocugen, Inc. | OCGN | Upgrade | Buy (Neutral) |
2.81 (0.92) |
-67.26% | Details | |
| 1/21/2021 | EDAP TMS S.A. | EDAP | Maintain | Buy (N/A) |
|
Details | ||
| 1/12/2021 | Vericel Corporation | VCEL | Maintain | Buy (N/A) |
|
Details | ||
| 1/5/2021 | Calithera Biosciences | CALA | Maintain | Buy (N/A) |
|
Details | ||
| 12/18/2020 | Surface Oncology | SURF | Maintain | Buy (N/A) |
|
Details | ||
| 11/27/2020 | Corcept Therapeutics | CORT | Maintain | Buy (N/A) |
|
Details | ||
| 11/17/2020 | Diffusion Pharma | DFFN | Downgrade | Neutral (Buy) |
0.66 (5.62) |
751.52% | Details | |
| 9/10/2020 | Trillium Therapeutics | TRIL | Upgrade | Buy (Neutral) |
13.59 (18.44) |
35.69% | Details | |
| 8/27/2020 | Personalis | PSNL | New Coverage | Buy (N/A) |
21.88 (2.60) |
-88.12% | Details | |
| 7/16/2020 | ReWalk Robotics Ltd. | RWLK | Maintain | Buy (N/A) |
|
Details | ||
| 6/26/2020 | Ekso Bionics | EKSO | Maintain | Buy (N/A) |
|
Details | ||
| 6/24/2020 | Precigen Inc. | PGEN | Maintain | Buy (N/A) |
|
Details | ||
| 6/15/2020 | Ekso Bionics | EKSO | Maintain | Buy (N/A) |
|
Details | ||
| 6/1/2020 | Ocugen, Inc. | OCGN | Downgrade | Neutral (Buy) |
0.31 (0.92) |
196.77% | Details | |
| 6/1/2020 | AVEO Pharmaceuticals | AVEO | Maintain | Buy (N/A) |
|
Details | ||
| 5/28/2020 | Mesoblast Limited | MESO | Maintain | Buy (N/A) |
|
Details | ||
| 5/12/2020 | Pulse Biosciences | PLSE | Upgrade | Buy (Neutral) |
11.74 (2.82) |
-75.98% | Details | |
| 4/7/2020 | Pluristem Therapeutics | PSTI | Maintain | Buy (N/A) |
|
Details | ||
| 4/3/2020 | Collplant Holdings Inc. | CLGN | Maintain | Buy (N/A) |
|
Details | ||
| 4/1/2020 | EDAP TMS S.A. | EDAP | Maintain | Buy (N/A) |
|
Details | ||
| 3/10/2020 | electroCore Inc. | ECOR | New Coverage | Buy (N/A) |
0.65 (5.34) |
721.54% | Details | |
| 3/6/2020 | Alphatec Holdings | ATEC | Maintain | Buy (N/A) |
|
Details | ||
| 3/3/2020 | Forty Seven Inc. | FTSV | Downgrade | Neutral (Buy) |
93.91 (95.51) |
1.7% | Details | |
| 2/14/2020 | Pulse Biosciences | PLSE | Downgrade | Neutral (Buy) |
12.18 (2.82) |
-76.85% | Details | |
| 2/12/2020 | IsoRay, Inc. | ISR | Maintain | Buy (N/A) |
|
Details | ||
| 2/6/2020 | Mesoblast Limited | MESO | Maintain | Buy (N/A) |
|
Details | ||
| 1/7/2020 | X4 Pharmaceuticals | XFOR | New Coverage | Buy (N/A) |
10.39 (0.84) |
-91.92% | Details | |
| 12/20/2019 | Ocugen, Inc. | OCGN | New Coverage | Buy (N/A) |
0.36 (0.31) |
-13.89% | Details | |
| 12/10/2019 | Forty Seven Inc. | FTSV | Maintain | Buy (N/A) |
|
Details | ||
| 11/19/2019 | Calithera Biosciences | CALA | New Coverage | Buy (N/A) |
3.38 (0.37) |
-89.05% | Details | |
| 11/11/2019 | Æterna Zentaris | AEZS | Maintain | Buy (N/A) |
|
Details | ||
| 10/28/2019 | Ekso Bionics | EKSO | New Coverage | Buy (N/A) |
0.59 (1.52) |
157.63% | Details | |
| 10/9/2019 | Vericel Corporation | VCEL | New Coverage | Buy (N/A) |
13.82 (28.97) |
109.62% | Details | |
| 9/17/2019 | Pluristem Therapeutics | PSTI | Maintain | Buy (N/A) |
|
Details | ||
| 9/12/2019 | Tocagen Inc. | TOCA | Downgrade | Neutral (Buy) |
4.18 (1.26) |
-69.86% | Details | |
| 9/11/2019 | AVEO Pharmaceuticals | AVEO | Upgrade | Buy (Neutral) |
0.92 (15.00) |
1530.43% | Details | |
| 9/6/2019 | Corcept Therapeutics | CORT | New Coverage | Buy (N/A) |
12.59 (21.77) |
72.92% | Details | |
| 8/19/2019 | Trillium Therapeutics | TRIL | Downgrade | Neutral (Buy) |
0.28 (18.44) |
6485.71% | Details | |
| 8/5/2019 | MediWound Ltd | MDWD | New Coverage | Buy (N/A) |
2.59 (12.12) |
367.95% | Details | |
| 6/17/2019 | ReWalk Robotics Ltd. | RWLK | Upgrade | Buy (Neutral) |
5.46 (0.68) |
-87.55% | Details | |
| 6/11/2019 | Sesen Bio, Inc | SESN | Upgrade | Buy (Neutral) |
2.32 (0.63) |
-72.84% | Details | |
| 6/5/2019 | Zomedica | ZOM | New Coverage | Buy (N/A) |
0.29 (0.21) |
-27.59% | Details | |
| 5/2/2019 | Cellectar Biosciences | CLRB | New Coverage | Buy (N/A) |
2.24 (1.51) |
-32.59% | Details | |
| 3/15/2019 | ReWalk Robotics Ltd. | RWLK | New Coverage | Neutral (N/A) |
0.23 (5.46) |
2273.91% | Details | |
| 3/14/2019 | Verastem | VSTM | Maintain | Buy (N/A) |
|
Details | ||
| 3/7/2019 | Gritstone Oncology | GRTS | New Coverage | Buy (N/A) |
12.03 (2.47) |
-79.47% | Details | |
| 2/25/2019 | Pulse Biosciences | PLSE | New Coverage | Buy (N/A) |
18.23 (12.18) |
-33.19% | Details | |
| 2/1/2019 | AVEO Pharmaceuticals | AVEO | Downgrade | Neutral (Buy) |
1.77 (0.92) |
-48.02% | Details | |
| 1/31/2019 | Mesoblast Limited | MESO | New Coverage | Buy (N/A) |
4.58 (3.09) |
-32.53% | Details | |
| 1/28/2019 | IsoRay, Inc. | ISR | New Coverage | Buy (Neutral) |
0.39 (0.38) |
-2.56% | Details | |
| 1/4/2019 | Sesen Bio, Inc | SESN | Downgrade | Neutral (Buy) |
1.47 (2.32) |
57.82% | Details | |
| 12/24/2018 | Histogenics Corp. | HSGX | Downgrade | Neutral (Buy) |
0.47 (0.16) |
-65.96% | Details | |
| 12/18/2018 | Advaxis | ADXS | Downgrade | Neutral (Buy) |
0.24 (1.35) |
462.5% | Details | |
| 12/18/2018 | Collplant Holdings Inc. | CLGN | New Coverage | Buy (N/A) |
4.10 (7.91) |
92.93% | Details | |
| 11/30/2018 | Forty Seven Inc. | FTSV | New Coverage | Buy (N/A) |
18.38 (95.51) |
419.64% | Details | |
| 10/15/2018 | Vascular Biogenics Ltd | VBLT | Upgrade | Buy (Neutral) |
1.43 (0.16) |
-88.81% | Details | |
| 8/17/2018 | Sesen Bio, Inc | SESN | Maintain | Buy (N/A) |
|
Details | ||
| 8/16/2018 | AVEO Pharmaceuticals | AVEO | New Coverage | Buy (N/A) |
2.32 (1.77) |
-23.71% | Details | |
| 8/13/2018 | Kindred Biosciences | KIN | Maintain | Buy (N/A) |
|
Details |
